vs

Side-by-side financial comparison of CDW Corporation (CDW) and Emerson Electric (EMR). Click either name above to swap in a different company.

CDW Corporation is the larger business by last-quarter revenue ($5.5B vs $4.3B, roughly 1.3× Emerson Electric). On growth, CDW Corporation posted the faster year-over-year revenue change (6.3% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $395.9M). Over the past eight quarters, CDW Corporation's revenue compounded faster (6.3% CAGR vs -0.3%).

CDW Corporation is an American multi-brand provider of information technology services, serving business, government, education, and healthcare sectors across the United States, the United Kingdom, and Canada. Headquartered in Vernon Hills, Illinois, CDW is a Fortune 500 and generated $21 billion in annual net sales in 2023.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

CDW vs EMR — Head-to-Head

Bigger by revenue
CDW
CDW
1.3× larger
CDW
$5.5B
$4.3B
EMR
Growing faster (revenue YoY)
CDW
CDW
+2.2% gap
CDW
6.3%
4.1%
EMR
More free cash flow
EMR
EMR
$206.1M more FCF
EMR
$602.0M
$395.9M
CDW
Faster 2-yr revenue CAGR
CDW
CDW
Annualised
CDW
6.3%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDW
CDW
EMR
EMR
Revenue
$5.5B
$4.3B
Net Profit
$605.0M
Gross Margin
22.8%
53.2%
Operating Margin
7.8%
17.8%
Net Margin
13.9%
Revenue YoY
6.3%
4.1%
Net Profit YoY
3.4%
EPS (diluted)
$2.13
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDW
CDW
EMR
EMR
Q4 25
$5.5B
$4.3B
Q3 25
$5.7B
$4.9B
Q2 25
$6.0B
$4.6B
Q1 25
$5.2B
$4.4B
Q4 24
$5.2B
$4.2B
Q3 24
$5.5B
$4.6B
Q2 24
$5.4B
$4.4B
Q1 24
$4.9B
$4.4B
Net Profit
CDW
CDW
EMR
EMR
Q4 25
$605.0M
Q3 25
$291.0M
$637.0M
Q2 25
$271.2M
$586.0M
Q1 25
$224.9M
$485.0M
Q4 24
$585.0M
Q3 24
$316.4M
$996.0M
Q2 24
$281.1M
$329.0M
Q1 24
$216.1M
$501.0M
Gross Margin
CDW
CDW
EMR
EMR
Q4 25
22.8%
53.2%
Q3 25
21.9%
51.9%
Q2 25
20.8%
52.6%
Q1 25
21.6%
53.5%
Q4 24
22.3%
53.5%
Q3 24
21.8%
51.3%
Q2 24
21.8%
52.8%
Q1 24
21.8%
52.2%
Operating Margin
CDW
CDW
EMR
EMR
Q4 25
7.8%
17.8%
Q3 25
7.7%
16.4%
Q2 25
7.0%
16.1%
Q1 25
7.0%
14.2%
Q4 24
7.9%
18.6%
Q3 24
8.7%
14.7%
Q2 24
8.0%
10.4%
Q1 24
6.7%
16.2%
Net Margin
CDW
CDW
EMR
EMR
Q4 25
13.9%
Q3 25
5.1%
13.1%
Q2 25
4.5%
12.9%
Q1 25
4.3%
10.9%
Q4 24
14.0%
Q3 24
5.7%
21.6%
Q2 24
5.2%
7.5%
Q1 24
4.4%
11.4%
EPS (diluted)
CDW
CDW
EMR
EMR
Q4 25
$2.13
$1.07
Q3 25
$2.21
$1.12
Q2 25
$2.05
$1.04
Q1 25
$1.69
$0.86
Q4 24
$1.97
$1.02
Q3 24
$2.34
$1.74
Q2 24
$2.07
$0.57
Q1 24
$1.59
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDW
CDW
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$2.6B
$20.3B
Total Assets
$16.0B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDW
CDW
EMR
EMR
Q4 25
$618.7M
Q3 25
$452.9M
Q2 25
$481.0M
Q1 25
$688.1M
Q4 24
$717.7M
Q3 24
$1.2B
Q2 24
$665.3M
Q1 24
$803.8M
Total Debt
CDW
CDW
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
CDW
CDW
EMR
EMR
Q4 25
$2.6B
$20.3B
Q3 25
$2.5B
$20.3B
Q2 25
$2.5B
$19.9B
Q1 25
$2.3B
$19.2B
Q4 24
$2.4B
$20.5B
Q3 24
$2.3B
$21.6B
Q2 24
$2.2B
$20.8B
Q1 24
$2.1B
$20.9B
Total Assets
CDW
CDW
EMR
EMR
Q4 25
$16.0B
$41.9B
Q3 25
$15.2B
$42.0B
Q2 25
$15.3B
$42.5B
Q1 25
$15.0B
$42.0B
Q4 24
$14.7B
$42.6B
Q3 24
$14.4B
$44.2B
Q2 24
$13.6B
$45.6B
Q1 24
$13.2B
$46.4B
Debt / Equity
CDW
CDW
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDW
CDW
EMR
EMR
Operating Cash FlowLast quarter
$433.8M
$699.0M
Free Cash FlowOCF − Capex
$395.9M
$602.0M
FCF MarginFCF / Revenue
7.2%
13.9%
Capex IntensityCapex / Revenue
0.7%
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDW
CDW
EMR
EMR
Q4 25
$433.8M
$699.0M
Q3 25
$328.3M
$3.1B
Q2 25
$155.9M
$1.1B
Q1 25
$287.2M
$241.0M
Q4 24
$345.3M
$777.0M
Q3 24
$342.1M
$3.3B
Q2 24
$149.9M
$1.1B
Q1 24
$440.0M
$743.0M
Free Cash Flow
CDW
CDW
EMR
EMR
Q4 25
$395.9M
$602.0M
Q3 25
$298.5M
$2.7B
Q2 25
$133.4M
$977.0M
Q1 25
$260.3M
$154.0M
Q4 24
$316.7M
$694.0M
Q3 24
$308.5M
$2.9B
Q2 24
$119.0M
$998.0M
Q1 24
$410.5M
$661.0M
FCF Margin
CDW
CDW
EMR
EMR
Q4 25
7.2%
13.9%
Q3 25
5.2%
54.9%
Q2 25
2.2%
21.5%
Q1 25
5.0%
3.5%
Q4 24
6.1%
16.6%
Q3 24
5.6%
63.1%
Q2 24
2.2%
22.8%
Q1 24
8.4%
15.1%
Capex Intensity
CDW
CDW
EMR
EMR
Q4 25
0.7%
2.2%
Q3 25
0.5%
8.9%
Q2 25
0.4%
2.0%
Q1 25
0.5%
2.0%
Q4 24
0.6%
2.0%
Q3 24
0.6%
9.1%
Q2 24
0.6%
2.1%
Q1 24
0.6%
1.9%
Cash Conversion
CDW
CDW
EMR
EMR
Q4 25
1.16×
Q3 25
1.13×
4.86×
Q2 25
0.57×
1.83×
Q1 25
1.28×
0.50×
Q4 24
1.33×
Q3 24
1.08×
3.35×
Q2 24
0.53×
3.31×
Q1 24
2.04×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDW
CDW

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons